
Upadacitinib Found Effective in Achieving Remission in Crohn Disease, Including Biologic-Experienced Patients
Upadacitinib demonstrated real-world effectiveness for inducing and maintaining clinical and endoscopic remission in patients with moderate-to-severe Crohn disease (CD), including those with prior advanced therapy exposure, according to results of a …